The authors used multivariate repeated-measures transition models to identify risk factors for two oral lesions related to human immunodeficiency virus (HIV)-candidiasis and hairy leukoplakia-in 152 HIVinfected blood transfusion recipients and hemophiliacs. Subjects were examined for occurrences of these lesions every 6 months from July 1985 through March 1993, yielding 1,076 study visits. It was found that, after adjustment for the CD4: CD8 T-lymphocyte ratio, patients with a history of candidiasis in the previous 18 months were at high risk of lesion recurrence. This risk increased with the number of prior episodes and with the recency of the episode(s). A history of hairy leukoplakia was less predictive of persistence of that lesion after adjustment for significant risk factors (including candidiasis and use of antifungal agents at the current examination, a low CD4: CD8 cell ratio, and age less than 40 years). The authors also found a high coprevalence of candidiasis and hairy leukoplakia in these subjects. These results suggest that HIV-infected patients with oral candidiasis should be carefully monitored for subsequent episodes over the next 12-18 months, and patients with either oral candidiasis or hairy leukoplakia and a low CD4 : CD8 cell ratio should be carefully examined for the other type of lesion as well. Am J Epidemiol 1997;145:164-74. 
the presence of oral candidiasis indicates the need for Pneumocystis carinii pneumonia prophylaxis in HIV-infected patients, regardless of their CD4 Tlymphocyte count (13) .
Despite their importance, relatively little is known about predictors of these oral lesions, although such information would improve our understanding of these opportunistic infections. Most studies of the natural history of HTV disease began by following HTVprevalent cohorts of subjects with unknown dates of seroconversion. However, one study which followed 80 HIV-infected homosexual men from seroconversion to their first episodes of oral candidiasis and hairy leukoplakia found that these lesions are common early manifestations of HTV disease: 18 percent of the men developed oral candidiasis and 35 percent developed hairy leukoplakia within 4 years (4) . Predictors of these lesions were not examined.
Candidiasis reflects infection by fungal organisms of the genus Candida. The standard of care for this lesion is treatment with topical or systemic antifungal medication, which usually resolves the lesion. (Reports of antifungal drug resistance among severely immunocompromised patients began to appear in 1991 (14) , near the end of our study period.) Hairy leukoplakia reflects a viral infection, presumably Epstein-
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Barr virus. No single treatment is commonly used for this lesion. The clinical course is highly variable, ranging from spontaneous remission within a short period of time to persistence over a very long period (15) .
The goals of this study were to estimate the risks of candidiasis and hairy leukoplakia among transfusion recipients and persons with hemophilia, to identify risk factors for these two lesions, and to determine whether transfusion recipients and hemophiliacs differ in their risks of episodes of oral lesions. We investigated San Francisco Bay Area residents who had been infected with HIV through contaminated blood or blood products. Subjects enrolled early in the study were identified through the San Francisco branch of the multicenter Transfusion Safety Study (16) (17) (18) (19) (20) (21) (22) (23) , which included persons recruited from San Francisco Bay Area hemophilia centers. Subjects enrolled late in the study were identified through the Look Back Study (24, 25) , which identified additional transfusion recipients by tracing recipients of HTV-contaminated blood or blood products.
MATERIALS AND METHODS Data collection
Subjects were HTV-infected hemophiliacs and transfusion recipients residing in the San Francisco Bay Area who had no other known HTV risk factors, were at least 1 year of age, and agreed to participate in longitudinal studies of the manifestations of HTV infection. We studied three cohorts of subjects (two transfusion recipient cohorts and one hemophiliac cohort) identified through the Transfusion Safety Study (TSS); through the hemophilia centers at the University of California, San Francisco and at Oakland Children's Hospital; and through the Look Back Study (LBS). The primary endpoint of interest in these cohort studies was the occurrence of AIDS. San Francisco was one of six clinical centers that participated in the Transfusion Safety Study; however, it was the only center that conducted longitudinal examinations for oral lesions. Thus, except for the oral examination data, all information and laboratory results for visits by the TSS and hemophilia cohorts were collected as part of that project and were made available to us for the present independent analysis.
HTV infection was defined as seropositivity for HTV-1 antibody by enzyme-linked immunoassay, confirmed by Western blot. Informed consent was obtained from all subjects (or their guardians) prior to participation.
Examinations for oral lesions and AIDS were conducted between July 1985 and March 1993. For TSS transfusion recipients, these study visits were scheduled every 3 months through 1989, and every 6 months thereafter; for the LBS transfusion recipients and the hemophiliacs, examinations were scheduled every 6 months. Study nurses trained by an oral medicine specialist (D. G.) to identify the oral manifestations of HTV infection performed the oral examinations and completed standardized forms developed by the University of California, San Francisco, Oral AIDS Center. Clinical diagnoses of oral candidiasis and hairy leukoplakia were accepted as definitive (26, 27) .
Immune system status, as measured by CD4 and CD8 T-lymphocyte counts, was also assessed at each examination. Use of antiviral agents, antifungal agents, and P. carinii pneumonia prophylaxis was recorded in the medical charts during the examinations, and this information was abstracted from the records at the time of the analysis.
Data analysis
We analyzed occurrences of oral candidiasis using transition models for longitudinal data in order to account for intrasubject correlations among responses while determining whether the occurrences depended on prior episodes of oral candidiasis (28) . We considered prior diagnoses of oral candidiasis at the four most recent examinations, as well as two-way and three-way interactions among these four events. Analysis of oral lesion status at four prior examinations reduces a data set considerably, since each subject must have at least five examinations and only the fifth can be analyzed to determine the prognostic value of the preceding four. Hence, to maximize the sample size, if no factor involving the least-recent prior examination was statistically significant at the 0.05 level in predicting a current candidiasis lesion, we removed these factors and reanalyzed the larger set of data. We continued this process using the backward selection mode for logistic regression modeling (which uses Wald x* statistics to identify significant predictors) until the best-fitting multivariate baseline transition model of prior visits was obtained. We did not allow for interactions involving more than three prior events in any of these models.
Subsequently, we added other subject characteristics to the set of variables defined by the baseline transition model above. Some subject characteristics were measured at each oral examination, and others were measured once per subject. Variables measured at each oral examination included current age, hairy leukoplakia status, three immune system markers (CD4 cell count, CD8 cell count, and CD4: CD8 cell ratio), three indicators of medication use (antiviral agents, antifun-gal agents, and P. carinii pneumonia prophylaxis), and years from enrollment to the current examination. Variables measured once per subject included years from HTV infection to study enrollment and indicators of risk group (transfusion recipient = 1/hemophiliac = 0), transfusion recipient cohort (LBS = 1/TSS = 0), and biologic sex (male = 1/female = 0). Both continuous (linear and quadratic) and categorical functions of age at lesion diagnosis were examined (the latter defined as seven age-decade indicators-e.g., age <30 years vs. >30 years). CD4 and CD8 cell counts were analyzed on the natural logarithmic scale.
Dates of HTV-infecting transfusions for the two transfusion recipient cohorts were identified through medical records (19) , but a single date (July 1, 1982) of infection was used as an estimate for all subjects in the hemophiliac cohort, all of whom were born prior to this date. Hemophiliacs in this study primarily had hemophilia type A (factor VHI insufficiency). In studying hemophiliacs with type A disease, Goedert et al. (29) found midpoint estimates of dates of HTV infection to be mid-1982 for those with severe disease and early 1984 for those with mild to moderate disease. Kroner et al. (30) also found differing median dates of HTV infection by subgroup, with an overall peak at October 1982 for patients from five US hemophilia centers. Our use of July 1982 is consistent with these estimates.
We identified subject characteristics that, when added to the baseline transition model, were statistically significant at the 0.05 level using backward selection. These variables were selected from subsets of related variables, as follows: age at lesion diagnosis; time from HTV infection to study enrollment and time from enrollment to current visit; three indicators of medication use; and hairy leukoplakia status and three immune system markers at the current visit. Subsequently, a multivariate model was formed by selecting from variables that were significant in an earlier model. If the multivariate model including subject characteristics was of a lower order than the baseline transition model (that is, if current oral candidiasis status depended on fewer prior visits after adjustment for other factors), then, in order to base estimates of effects of predictors on a larger sample size, we refitted this model with the nonsignificant prior examinations omitted (without further backward selection). This model was evaluated for lack of fit using regression diagnostic statistics (DFBETAS, X*, hat-matrix values, and confidence interval displacement statistics (31)), as well as the Hosmer-Lemeshow test (32) .
Sex differences were assessed in the final model, restricted to the subsample of transfusion recipients. Lastly, to determine whether transfusion recipients and hemophiliacs differed in their risks of candidiasis after adjustment for other risk factors, we added cohort indicators to the multivariate model.
Occurrences of hairy leukoplakia were modeled similarly to determine whether they could be predicted by up to four earlier episodes of hairy leukoplakia and by other subject characteristics.
Model fitting was performed using SAS software (32) . The SAS logistic regression procedure deletes examinations with any missing data on the variables included in the model.
RESULTS

Subjects
We enrolled 154 subjects and conducted a total of 1,087 oral examinations. This report is based on the 99 percent of study visits for which CD4 and CD8 Tlymphocyte counts were available. The number of examinations per subject ranged from 1 to 20; 79 percent of subjects had at least two examinations, 69 percent had at least three examinations, and 63 percent had at least four examinations (table 1) . Overall, candidiasis was diagnosed approximately twice as often as hairy leukoplakia. Table 1 shows the number of visits available for analysis, based on a cross-sectional model (the minimum number of visits per subject is 1, and each visit is considered to be independent) and based on longitudinal transition models (in which the minimum numbers of visits per subject are two, three, four, and five, respectively). For example, for a first-order transition model, each subject must have had at least two study visits so that the dependence of the current outcome on the previous outcome can be analyzed. A subject with three study visits contributes two responses (from visits 2 and 3) to the analysis when a first-order model is used. Thus, although oral lesion and immune system data were collected at 1,076 visits, only 926 visits were available for analysis of one prior outcome.
The percentages of examinations at which oral candidiasis and hairy leukoplakia were diagnosed increased as the minimum number of examinations per subject increased and subjects with few examinations were excluded (table 1). To determine whether there was differential participation of subjects by oral candidiasis status, we compared the proportions remaining under follow-up at visits 2 through 12 by oral candidiasis status at the previous visit. Of subjects without oral candidiasis, 80 percent (visit 2) to 96 percent (visit 8) returned. Of subjects with oral candidiasis, the return rates were lower by more than 8 percent at visits 2-4 and 12, but otherwise differed by less than 8 percent. We also found that the prevalence of oral candidiasis increased with visit number. Thus, the increasing lesion rates by "minimum number of examinations" (table 1) probably reflect progression of HTV disease over time.
All but four subjects with hemophilia were male, whereas the transfusion recipients were nearly equally divided between males and females (table 2). The hemophiliacs were young, on average: 22 percent were under 18 years of age and 90 percent were under age 45 at the approximate date of HTV infection (July 1, 1982); the youngest was 1 year old, and the oldest was 60. In contrast, transfusion recipients ranged in age at HTV infection (known date was used) from 1 to 87 years, with 44 percent being under age 45. Transfusion recipients from the Transfusion Safety Study tended to be older than those identified by the Look Back Study.
At enrollment, 30 percent of subjects had CD4 cell counts less than 200 cells/mm 3 , and 71 percent had CD4 counts less than 500 cells/mm 3 . Nearly three times as many LBS subjects as other subjects had CD4 counts less than 200 cells/mm 3 (49 percent vs. 19 percent) and CD4: CD8 cell ratios less than 0.25 (45 percent vs. 12 percent) (table 2).
The medication histories of 54 transfusion recipients (58 percent) and 46 hemophiliacs (78 percent), corresponding to 90 percent of study visits, were available. During follow-up, antiviral agents were taken by 60 percent of subjects with medication histories, P. cari- nii pneumonia prophylaxis was used by 40 percent of subjects, and antifungal agents were taken by 20 percent of subjects. Antiviral agents reported in medical charts included zidovudine, didanosine, dideoxycitidine, and acyclovir; P. carinii pneumonia prophylactic agents included trimethoprim, sulfamethoxazole, aerosolized and intravenous pentamidine, and dapsone; and antifungal agents included clotrimazole, nystatin, ketoconazole, fluconazole, and amphotericin. The lag time between infection and enrollment varied by cohort. For LBS transfusion recipients, the median lag time was 8.2 years, and for TSS transfusion recipients it was 1.6 years (figure 1). Among LBS transfusion recipients, HTV infections occurred between 1979 and 1986 and study enrollment between 1988 and 1993, while among TSS transfusion recipients, infections occurred in 1984 or 1985 and enrollment between 1985 and 1987 (figure 2). Most subjects with hemophilia were enrolled between 1985 and 1986, but two subjects who transferred from other centers were enrolled in 1988 and 1991, respectively. Assuming a common infection date of July 1, 1982, the hemophiliacs' median time from infection to enrollment was 3.5 years (figure 1).
Occurrence of oral candidiasis
We found that oral candidiasis status at each of the three most recent visits was significantly associated with current oral candidiasis status, as was the interaction between the two most recent examinations (table 3, model 1; 703 examinations of 96 subjects). This third-order transition model refined the average rate of oral candidiasis occurrence (19.8 percent) obtained from the cross-sectional analysis (table 1) . The model estimated that subjects without candidiasis at any of the three previous study visits had the lowest risk of candidiasis at the current visit-9.2 percentwhereas subjects with candidiasis only at the third-most-recent visit had a probability of 15.2 percent; at the second-most-recent, 36.4 percent; and at the most recent visit, 53.0 percent. The risk did not increase substantially above 50 percent for subjects who had had candidiasis at more than one prior visit; the interaction term served to reduce accumulation of risk for subjects with lesions at both of the two most recent visits.
When additional subject characteristics were added in sets (see "Materials and Methods") to this baseline transition model, backward selection identified the following factors as statistically significant: CD4: CD8 T-lymphocyte ratio, hairy leukoplakia at the current visit, log CD8 cell count, and use of antiviral agents. These four variables were added jointly to the baseline transition model, and the most prognostic subset was identified using backward selection. The resultant model included oral candidiasis status at two previous examinations and their interaction, hairy leukoplakia status at the current examination, CD4 : CD8 cell ratio, and antiviral medication use; log CD8 cell count was marginally significant. To increase the sample size, we refitted the multivariate model while excluding lesion status at the third-most-recent visit (777 examinations of 92 subjects), and this model was evaluated using regression diagnostics. Years from infection to enrollment Lack of fit of the model was assessed by examining four diagnostic statistics, even though the HosmerLemeshow test (x 2 -11 A, 8 df) showed that the model fitted well. Three study visits were outliers according to at least two of these statistics. The CD4: CD8 cell ratios recorded at these three study visits were in the 98th percentile or higher, and the subjects had no prior history of oral candidiasis and did not have current hairy leukoplakia; all had current oral candidiasis and were on antiviral medication. Exclusion of these data points reduced the effect of antiviral drug use (odds ratio (OR) = 1.70-1.45) to nonsignificance and increased the effect of log CD8 count. Thus, the final model constructed included log CD8 count but omitted these three data points and antiviral drug use (and thereby gained 30 observations in which data on this variable were missing (table 3, model 2): 804 examinations of 105 subjects); the Hosmer-Lemeshow value was 9.90 (8 df).
The odds ratios associated with prior oral candidiasis were less strong after we adjusted the data for other covariates, but they still indicated a strong tendency • HIV, human immunodeficiency virus; OR, odds ratio; Cl, confidence interval; LBS, Look Back Study. t Three examinations (outliers) with oral candidiasis diagnoses were excluded; one was in an LBS transfusion recipient and two were in hemophiliacs.
X Oral candidiasis status at study visit 1, 2, or 3 prior to the current visit toward recurrence of this lesion. The interaction term indicated that the odds of oral candidiasis were only slightly higher for subjects with oral candidiasis at both prior visits (OR = 8.82 X 3.76 X 0.290 = 9.62) than for those with oral candidiasis at just the most recent visit (OR = 8.82). Conditional on a subject's oral candidiasis history, there was a significant increase in the odds of oral candidiasis with decreases in the CD4:CD8 ratio (OR = 0.211) and the log CD8 count (OR = 0.774), reflecting deterioration of immune function. These terms indicated that some aspect of the predictive power of prior lesions (model 1) was captured better by these immune system measures (model 2). Finally, the model indicated that the odds of oral candidiasis were higher for subjects who were diagnosed with hairy leukoplakia at the current examination, indicating a tendency toward coprevalence of these types of lesions. (model 3, table 3 ). The LBS cohort is unusual in that relatively few oral candidiasis diagnoses were made despite low CD4: CD8 ratios. The effect of the LBS indicator on the model was to reduce the intercept for that group, reflecting its lower odds of oral candidiasis after adjustment for other risk factors (see also table 4). For model 3, the median numbers of examinations analyzed per subject were 2.5 (range, 1-7) for 18 LBS subjects, five (range, 1-18) for 34 TSS subjects, and six (range, 1-14) for 53 hemophiliacs.
Finally, two special cases were considered. Biologic sex was added to model 2 and hemophiliacs, almost none of whom were female, were excluded; the increased odds ratio among males was nonsignificant (OR = 1.23, 95 percent confidence interval (CI) 0.63-2.42). In addition, because the TSS cohort was examined more frequently (at 3-month intervals) prior to 1990, we wanted to ensure that the influence of the two preceding examinations on current oral candidiasis status was not being driven by events occurring at closely spaced intervals. We therefore limited the TSS data to examinations conducted in 1990 or later and refitted model 2. All predictors remained highly significant, and only the estimated effect of the CD4: CD8 ratio decreased.
Occurrence of hairy leukoplakia
Previous diagnoses of hairy leukoplakia at the most recent, second-most-recent, and third-most-recent study visits were all significant predictors of a current diagnosis of hairy leukoplakia. The two-way interaction between the most recent and third-most-recent examinations was also significant, while that between the second-and third-most-recent examinations was not; however, both effects were of similar magnitude, and thus both were retained in the model. The CTOSSsectional estimate of hairy leukoplakia occurrence among 96 subjects examined at least four times each was 10.5 percent (table 1). The "baseline transition model," however, indicated that the estimate of hairy leukoplakia risk was only 6.5 percent for subjects widi no episodes of hairy leukoplakia at the previous three examinations, and that it increased to 18.9 percent, 21.8 percent, and 28.9 percent for subjects with one prior episode of hairy leukoplakia at the third-mostrecent, second-most-recent, and most recent examinations, respectively. The risk increased for subjects with prior episodes at both of the two most recent examinations (to 62.0 percent), but it did not increase for subjects with multiple prior hairy leukoplakia diagnoses at other combinations of visits (range, 11.1-27.0 percent).
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In separate models of sets of predictors added to this baseline model (see "Materials and Methods"), we identified four factors as statistically significant: age at infection, use of antifungal agents, diagnosis of oral candidiasis at the current visit, and CD4: CD8 cell ratio. A multivariate model of hairy leukoplakia occurrence was found by selecting factors from the baseline transition model in addition to these four subject characteristics. Only the most recent hairy leukoplakia diagnosis was significant in this model, reducing it to a first-order transition (Markov) model after adjustment for covariates. All four predictors evaluated remained statistically significant in this model (874 examinations of 98 subjects; 52 examinations were omitted because of missing data on use of antifungal agents). In addition, because antifungal medications are used to treat oral candidiasis and both of these terms were significant predictors, we also included the interaction between these terms. Although results were not statistically significant, the interaction term had a nonnegligible effect on other parameter estimates.
After adjustment for other covariates, the odds ratio for a current diagnosis of hairy leukoplakia was 2.79 (95 percent CI 1.45-5.37) in subjects with hairy leukoplakia at the previous examination relative to subjects without prior hairy leukoplakia. However, current oral candidiasis, antifungal drug use, and CD4: CD8 ratio were even stronger predictors of hairy leukoplakia status. The model estimated that, relative to subjects without oral candidiasis who were not using antifungal agents, the odds ratio for hairy leukoplakia was 9.96 (95 percent CI 3.84-25.8) among subjects with oral candidiasis who were taking antifungal agents, 5.47 (95 percent CI 3.04-9.84) among subjects with oral candidiasis who were not taking antifungal agents, and 3.53 (95 percent CI 1.13-11.0) among subjects who were taking antifungal agents and were currently free of clinical oral candidiasis. The occurrence of hairy leukoplakia also was strongly associated with a decreasing CD4: CD8 ratio (OR = 0.24, 95 percent CI 0.092-0.61).
Age at diagnosis was the least significant predictor. After examining both continuous and categorical functions of age (see "Materials and Methods"), we found that an indicator of age less than 40 years at examination was associated with increased risk of hairy leukoplakia (OR = 1.91, 95 percent CI 1.09-3.35). This model fitted slightly better than a model including linear age (with fit determined by the likelihood ratio and Hosmer-Lemeshow tests). Because hairy leukoplakia has rarely been reported in children, we examined the marginal distribution of hairy leukoplakia episodes by age more closely. Of 874 modeled examinations, 54 percent of episodes occurred when subjects were under age 40. There were at least 50 examinations per decade in subjects' second through eighth decades of life, but 32 or fewer examinations in decades outside of this range. The youngest case of hairy leukoplakia was seen in a subject aged 11 years at diagnosis, and the oldest was seen in a person aged 75. Thus, no cases were observed among children, although three were expected assuming no association with age.
The fit of the multivariate model discussed here was evaluated using regression diagnostics. Only one data point was an outlier by two criteria, and four data points were outliers by extreme values of the x 1 statistic alone. The first outlier patient had oral candidiasis at his two previous and two subsequent visits but not at the current visit, and he was on antifungal medication. We changed his current oral candidiasis status to "present" in the model results reported here, which caused an increase in the oral candidiasis parameter estimate and a decrease in the antifungal use parameter estimate. Each of the remaining outliers appeared biologically plausible when examined in the light of the subject's other study visits, and no additional data points were changed or dropped from the analysis (e.g., the subject with oral candidiasis experienced a substantial drop in CD4 count just before or after the visit, the subject with oral candidiasis was also diagnosed with hairy leukoplakia at his next two visits, etc.).
In other risk groups, we have observed a positive association between hairy leukoplakia and male gender (33) . To investigate this association among transfusion recipients and hemophiliacs, we added gender to the final model, but restricted this analysis to the transfusion recipient subsample because there are so few female hemophiliacs. We found only very weak support for a greater risk of hairy leukoplakia among males (OR = 1.37, 95 percent CI 0.56-3.32) which was not statistically significant. Finally, we also tested the difference in risk of hairy leukoplakia between transfusion recipients and hemophiliacs, while controlling for the factors identified above. The odds of hairy leukoplakia were also slightly higher in transfusion recipients, but not to a clinically or statistically significant degree (OR = 1.38, 95 percent CI 0.77-2.47).
DISCUSSION
We found that oral candidiasis and hairy leukoplakia are common lesions in HTV-infected transfusion recipients and hemophiliacs, with a higher prevalence of oral candidiasis than of hairy leukoplakia (18 percent vs. 9 percent, on average, among subjects with at least three examinations). By contrast, among men who had had sex with men, Lifson et al. (4) found a lower incidence of oral candidiasis than of hairy leukoplakia (18 percent vs. 35 percent 4 years post-HTV infection). In HTV-infected women, Shiboski et al. (34) observed that oral candidiasis lesion rates were higher than hairy leukoplakia lesion rates in intravenous drug users but lower in heterosexuals. Women in the former group may resemble transfusion recipients and hemophiliacs in that they probably were infected with HIV parenterally, whereas women in the latter group may resemble men who have sex with men in that they were probably infected with HTV through sexual activity. The consistency of the associations between oral lesions and route of virus transmission supports theories positing a viral (Epstein-Barr) etiology for hairy leukoplakia, wherein mat virus or some cofactor for it is transmitted sexually. More generally, the differences among cohorts in expression of candidiasis and hairy leukoplakia may be associated with risk-group-specific comorbidities.
The odds of occurrence of an oral candidiasis lesion were far greater among persons in whom oral candidiasis lesions had been diagnosed in the preceding 6-18 months than in persons without prior diagnoses. The strength of this prediction decreased for increasingly remote prior examinations, ranging from a probability of 53 percent if the candidiasis had been diagnosed 6 months previously to 15 percent if it had been diagnosed 18 months previously. By contrast, the odds of oral hairy leukoplakia were only weakly associated with prior hairy leukoplakia episodes, with risks of 29 percent and 19 percent if hairy leukoplakia had been diagnosed 6 and 18 months previously, respectively. These findings are consistent with oral candidiasis being a readily recurrent manifestation of Candida infection(s) and with hairy leukoplakia being a persistent lesion reflecting (onetime) Epstein-Barr virus infection.
For candidiasis, prior oral candidiasis lesions remained the strongest predictors after adjustment for concomitant hairy leukoplakia and for CD4: CD8 ratio and log CD8 cell count. For hairy leukoplakia, however, the effects of concomitant oral candidiasis and antifungal use were stronger predictors than CD4: CD8 ratio or prior hairy leukoplakia lesions. The association between hairy leukoplakia and antifungal use seen after adjustment for current oral candidiasis status may reflect prior oral candidiasis episodes. The strong interrelation between these types of lesions in both models warrants further investigation at both the epidemiologic (in other risk groups) and the molecular level.
We found higher odds of hairy leukoplakia before age 40 than afterward, but found no association between age at study visit and oral candidiasis occurrence. In contrast, Eyster et al. (10) reported higher incidence rates of both oral candidiasis and hairy leukoplakia among hemophiliacs over 18 years of age compared with younger persons; however, they did not report the age distribution or the uppermost age of their subjects. In our study, only 4 percent of examinations were conducted in persons under 10 years old, and no cases of hairy leukoplakia were observed in this group; only 9 percent of examinations were conducted in persons at least 70 years old, and only one hairy leukoplakia case was observed in these persons. Thus, we had low power to detect the shape of the association between hairy leukoplakia and age at these extremes; a concave association could be consistent with both Eyster et al.'s study and our report.
A priori, one might hypothesize that use of antiviral medication would reduce the risk of oral lesions, just as it can induce an increase in CD4 cell counts. In fact, however, Lamster et al. (35) reported significantly more oral lesions (of unspecified type) with antiviral use in a cohort of men who had had sex with men, suggesting that use of antiviral agents distinguishes persons at a later stage of HTV disease progression for whom clinicians have prescribed antiviral drugs. We also found a positive association between antiviral use and oral candidiasis occurrence, but it was not statistically significant in a multivariate model.
No difference in risk of oral candidiasis or hairy leukoplakia was found between transfusion recipients and hemophiliacs. However, the risk of oral candidiasis was somewhat lower for the LBS transfusion recipient cohort than for the other two cohorts after adjustment for significant predictors. Interpreting this result is difficult because at least two variables were confounded with cohort: time from HTV infection to study enrollment and length of follow-up after enrollment. Median times from HTV infection to enrollment ranged from 8.2 years for LBS transfusion recipients to 1.6 years for TSS transfusion recipients; however, time from infection to enrollment was not a significant predictor of oral candidiasis occurrence. Follow-up of all three cohorts ended in March 1993; thus, differential follow-up was due to later enrollment of the LBS transfusion recipients. These differences between cohorts suggest a biologic reason for the lower risk of oral candidiasis observed in the LBS transfusion recipients despite their substantially longer time from HTV infection to enrollment: Since all subjects were ATDS-free at enrollment, the LBS transfusion recipient cohort was a naturally selected subset of individuals who had generally remained AIDS-free for a longer time from infection and were also relatively healthy in terms of oral lesions.
Subjects' knowledge of their history of oral lesions should not have influenced the probability of diagnosis in this study, because AIDS was the study's primary endpoint and oral lesions were assessed during routinely scheduled visits. We compared participation rates of subjects by lesion status and found no excess participation by persons with lesions. In the TSS cohort, examinations were scheduled at 3-month intervals during the early years of the study (1985) (1986) (1987) (1988) (1989) . We were able to confirm that current oral candidiasis status depended on oral candidiasis diagnoses at the three preceding examinations, even if they were timed at 6-month intervals, by also restricting the analysis to 6-month interval data.
Although examinations were scheduled at equal intervals, subjects were not examined exactly on schedule; furthermore, some scheduled examinations were missed by study participants. To adjust for this variation, we evaluated the effect of time from enrollment to the current examination on lesion occurrence. This variable was not found to be significant in predicting the occurrence of either candidiasis or hairy leukoplakia. It was excluded from our models, which thus assumed equal time between examinations.
Diagnoses of oral lesions in this study were made without confirmation by biopsy or tissue culture. It may be that some subjects were not truly at risk of these lesions because they were not carriers of the causative agents, Candida species and Epstein-Barr virus. In an effort to minimize misclassification bias, however, one oral medicine specialist trained all other clinicians (physicians, dentists, and nurses) throughout the study, and seven clinicians performed 94 percent of the 873 oral examinations for which the examiner's name was noted. Four of these seven clinicians examined patients in all three cohorts, accounting for 51 percent of the hemophiliacs' examinations, 40 percent of the TSS transfusion recipients' examinations, and 94 percent of the LBS transfusion recipients' examinations. Clinicians were unaware of subjects' oral lesion histories during examinations.
Our finding that HTV-infected transfusion recipients and hemophiliacs with a history of candidiasis are at high risk of recurrence suggests that such patients should be monitored closely for at least 18 months for new episodes. Although these patients might benefit from antifungal prophylaxis, such benefit must be weighed against the potential for development of drugresistant strains of Candida species. Hairy leukoplakia also tends to persist; however, more significant risk factors than history of this lesion include the presence of an oral candidiasis lesion, poor immune system status, and younger adult age (<40 years). The high coprevalence of candidiasis and hairy leukoplakia in these subjects suggests that if one type of lesion is found, clinicians should look carefully for the other type of lesion as well. The risk factors identified here were all statistically significant in multivariate repeated-measures transition models after adjustment for CD4: CD8 ratios.
